Tekmira Delays Start of Cancer Drug Trial, Sees Expanded Roche Partnership in '09

The company also released its fourth-quarter financial results, posting higher losses on increased research and development spending as it worked to move its first drug into the clinic this year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories